Gene · 4298
Papers1,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YEATS2 O-GlcNAcylation promotes chromatin association of the ATAC complex and lung cancer tumorigenesis. | J Biol Chem | 2025 | 40541806 | PubTator, text mining | PubMed |
| [Screening of MLL fusion genes and rare breakpoint cases in patients with acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | 40425457 | PubTator, text mining | PubMed |
| The YEATS domain is a selective reader of histone methacrylation. | Structure | 2025 | 40339582 | PubTator, text mining | PubMed |
| Umbilical cord blood-derived platelet-rich plasma as a coating substrate supporting cell adhesion and biological activities of wound healing. | Eur J Med Res | 2025 | 40022270 | PubTator, text mining | PubMed |
| Epigenome-wide association study of Chinese monozygotic twins identifies DNA methylation loci associated with estimated glomerular filtration rate. | J Transl Med | 2025 | 39844292 | PubTator, text mining | PubMed |
| Creating coveted bioluminescence colors for simultaneous multi-color bioimaging. | Sci Adv | 2025 | 39841832 | PubTator, text mining | PubMed |
| Predicting fragment binding modes using customized Lennard-Jones potentials in short molecular dynamics simulations. | Comput Struct Biotechnol J | 2025 | 39816914 | PubTator, text mining | PubMed |
| A multivalent engagement of ENL with MOZ. | Nat Struct Mol Biol | 2025 | 39794553 | Swiss-Prot, curated | PubMed |
| Prospects for the Protective Mechanisms and Compounds of Bufei Huoxue Capsule against COVID-19 Convalescence: Evaluation of Integrating UHPLC-HRMS Analysis and Network Pharmacology Strategy. | Comb Chem High Throughput Screen | 2025 | 38920066 | PubTator, text mining | PubMed |
| Rare cases of a second recurrence of nephroblastoma with MLLT1 gene mutation: case report and literature review. | Front Oncol | 2024 | 39687897 | PubTator, text mining | PubMed |
| Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia. | J Med Chem | 2024 | 39530508 | PubTator, text mining | PubMed |
| MLL oncoprotein levels influence leukemia lineage identities. | Nat Commun | 2024 | 39472576 | PubTator, text mining | PubMed |
| The histone acylation reader ENL/AF9 regulates aging in Drosophila melanogaster. | Neurobiol Aging | 2024 | 39405796 | PubTator, text mining | PubMed |
| Marmoset and human trophoblast stem cells differ in signaling requirements and recapitulate divergent modes of trophoblast invasion. | Cell Stem Cell | 2024 | 39321797 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the role of RNA modification regulators in polycystic ovary syndrome. | Heliyon | 2024 | 39281527 | PubTator, text mining | PubMed |
| Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs. | ACS Chem Biol | 2024 | 39264973 | PubTator, text mining | PubMed |
| HOXA9 Regulome and Pharmacological Interventions in Leukemia. | Adv Exp Med Biol | 2024 | 39017854 | PubTator, text mining | PubMed |
| Single-cell multiomics reveals ENL mutation perturbs kidney developmental trajectory by rewiring gene regulatory landscape. | Nat Commun | 2024 | 39009564 | PubTator, text mining | PubMed |
| DNA break induces rapid transcription repression mediated by proteasome-dependent RNAPII removal. | Cell Rep | 2024 | 38954517 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4298/papers?page=3